SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian's stock is trending amid discussions about potential quality control issues and their impact on vehicle reliability and service experiences. The community is actively debating the long-term viability of Rivian's vehicles and software, as well as the impact of potential delays in production of the R2 model. Some investors express optimism, pointing to positive chart patterns and potential catalysts, while others remain skeptical, citing concerns about cash burn and competition in the EV sector.

The national debt has increased every year for the past ten years, and interest expenses have remained fairly stable due to low interest rates and the perceived low risk of U.S. government default, according to the U.S. Treasury Fiscal Data. This coin is a parody coin about the debt crises in the US and to highlight various aspects about this crises in a humouros way to the people on solana. $USNDC

UnitedStates National Debt Coin

UnitedStates National Debt Coin ($USNDC.X) is trending as community members discuss its potential for significant upward movement, with some mentioning 'moon' and 'rocket' emojis. Conversations highlight growing liquidity and grassroots energy, particularly within the Phantom wallet ecosystem on Solana. However, some users are advising caution, pointing to a connection with a past project.

Fwog

Fwog is trending as the community rallies behind the meme coin, with many believing it's undervalued and poised for significant gains. Discussions highlight its potential to be the next breakout meme coin on the Solana network, drawing comparisons to other successful projects. Some investors are noting the strong community and unique artwork as key drivers for its future success.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as the community discusses the company's recent earnings, potential acquisitions, and the competitive landscape with new drugs entering the hereditary angioedema (HAE) market. Community members are debating the impact of competitor Ionis's newly approved drug, Dawnzera, on Biocryst's market share, while also speculating about a potential buyout. The stock's price action, especially in light of positive financial results, remains a key point of contention and frustration among investors.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company’s website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

ROKU is trending as the community discusses its ad revenue potential and recent price action following earnings, with some seeing a buying opportunity amidst the volatility. Bullish sentiment is fueled by the Amazon partnership and potential growth in streaming hours, while bears point to profitability concerns and potential market cap corrections. Overall, investors are weighing ROKU's strategic shifts in the competitive streaming landscape.

Elizabeth is Solana’s meme cat, gentle, sweet, and a little chubby, loved by the community as the official mascot of Solana. She represents the fun side of crypto culture, bringing people together with her charm and personality, while showing that Solana is not only about technology but also about creativity, community, and joy. Elizabeth is also a charity token, with part of the revenue used to support shelters.🐈‍⬛

Just Elizabeth Cat

ELIZABETH.X is trending due to social media promotion by the founder of Solana, generating excitement within the crypto community. The token's low market cap is being highlighted as an opportunity for substantial gains. Community members are actively comparing it to other meme coins like PEPE.X.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE.X is trending as the community anticipates potential rallies and discusses entry points, despite some expressing frustration with recent price action. Conversations revolve around whether PEPE.X will follow broader market trends or if it will breakout independently. Some traders are also weighing PEPE.X against other meme coins, looking for the next big runner.

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Jazz Pharmaceuticals plc

Jazz Pharmaceuticals is trending as investors discuss the potential impact of IXHL's REPOSA sleep apnea therapy on the sleep disorder market, drawing comparisons to Jazz's existing sleep-related drugs; some believe Jazz or other Big Pharma companies could partner with or acquire IXHL if clinical results are positive. Additionally, Jazz recently secured FDA approval for Modeyso brain cancer therapy, and analysts are weighing the impact of a Chimerix-related charge on the company's growth model.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Biogen Inc

Biogen ($BIIB) is trending as traders weigh the impact of a recent FDA roadblock for its Spinraza drug amid ongoing European regulatory reviews. The community is also actively discussing potential support trendlines and call option strategies. Positive sentiment stems from recent EU approval for Zurzuvae, a postpartum depression drug.

Toast, Inc. engages in the development and provision of consumer payment application for restaurants. It offers terminals, kiosk, guest facing display, and system accessories. The firm also offers point of sale, reporting and analytics, online ordering and delivery, and kitchen display system. The company was founded by Jonathan Grimm, Aman Narang, and Stephen J. Fredette in December 2011 and is headquartered in Boston, MA.

Toast Inc - Ordinary Shares - Class A

Toast Inc

Toast ($TOST) is trending as investors discuss its potential following recent price movements and anticipation for upcoming earnings, with some highlighting its growth prospects and market position in the restaurant technology sector. Community members are actively debating entry points, potential price targets, and the impact of insider selling, while also weighing positive factors like partnerships and international expansion. Some believe $TOST is undervalued and poised for significant growth, while others express concerns about valuation and discretionary spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This account has been verified as a SEBI Research Analyst (RA).

Financewithpalak

Finance With Palak